Keywords: GlaxoSmithKline, Human Genome, M&A

Is GlaxoSmithKline eyeing a $4 billion bid for Human Genome?

Article | 26 August 2009

Print This

Suggestions that UK drug giant GlaxoSmithKline is planning a takeover of development partner Human Genome Sciences for $30/share - or ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in